Copy number variations inDCC/18q andERBB2/17q are associated with disease-free survival in microsatellite stable colon cancer
出版年份 2017 全文链接
标题
Copy number variations inDCC/18q andERBB2/17q are associated with disease-free survival in microsatellite stable colon cancer
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CANCER
Volume 140, Issue 7, Pages 1653-1661
出版商
Wiley
发表日期
2016-12-24
DOI
10.1002/ijc.30584
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Prognostic role of ERBB2, MET and VEGFA expression in metastatic colorectal cancer patients treated with anti-EGFR antibodies
- (2016) Naoki Takahashi et al. BRITISH JOURNAL OF CANCER
- Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
- (2016) Andrea Sartore-Bianchi et al. LANCET ONCOLOGY
- Droplet digital PCR measurement of HER2 in patients with gastric cancer
- (2015) H Kinugasa et al. BRITISH JOURNAL OF CANCER
- Rectal and colon cancer: Not just a different anatomic site
- (2015) K. Tamas et al. CANCER TREATMENT REVIEWS
- A prognostic analysis of 895 cases of stage III colon cancer in different colon subsites
- (2015) Yan Zhang et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Molecular Subtypes in Stage II-III Colon Cancer Defined by Genomic Instability: Early Recurrence-Risk Associated with a High Copy-Number Variation and Loss of RUNX3 and CDKN2A
- (2015) Marianne Berg et al. PLoS One
- Dependence receptors and colorectal cancer
- (2014) Patrick Mehlen et al. GUT
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- ERCC1, XRCC1 and GSTP1 Single Nucleotide Polymorphisms and Survival of Patients with Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy
- (2014) Aziz Zaanan et al. Journal of Cancer
- Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations
- (2013) Dmitri Mouradov et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients
- (2013) V Martin et al. BRITISH JOURNAL OF CANCER
- Noninvasive Detection of HER2 Amplification with Plasma DNA Digital PCR
- (2013) H. Gevensleben et al. CLINICAL CANCER RESEARCH
- Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer
- (2013) Lenora W. M. Loo et al. GENES CHROMOSOMES & CANCER
- Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions
- (2013) Felipe De Sousa E Melo et al. NATURE MEDICINE
- A colorectal cancer classification system that associates cellular phenotype and responses to therapy
- (2013) Anguraj Sadanandam et al. NATURE MEDICINE
- Identification of Candidate Driver Genes in Common Focal Chromosomal Aberrations of Microsatellite Stable Colorectal Cancer
- (2013) George J. Burghel et al. PLoS One
- Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
- (2013) Laetitia Marisa et al. PLOS MEDICINE
- Deleted in Colorectal Cancer (DCC) Pathfinding: Axon Guidance Gene Finally Turned Tumor Suppressor
- (2012) Molly Duman-Scheel CURRENT DRUG TARGETS
- Association between genomic alterations and metastatic behavior of colorectal cancer identified by array-based comparative genomic hybridization
- (2012) Takeshi Sawada et al. GENES CHROMOSOMES & CANCER
- Chromosomal Instability (CIN) Phenotype, CIN High or CIN Low, Predicts Survival for Colorectal Cancer
- (2012) Toshiaki Watanabe et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer
- (2012) A. D. Roth et al. JNCI-Journal of the National Cancer Institute
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- A Molecularly Annotated Platform of Patient-Derived Xenografts ("Xenopatients") Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
- (2011) A. Bertotti et al. Cancer Discovery
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Prognostic Significance and Molecular Associations of 18q Loss of Heterozygosity: A Cohort Study of Microsatellite Stable Colorectal Cancers
- (2009) Shuji Ogino et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
- (2009) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
- CpG Island Methylator Phenotype Associates with Low-Degree Chromosomal Abnormalities in Colorectal Cancer
- (2008) Y.-W. Cheng et al. CLINICAL CANCER RESEARCH
- Genomic and Epigenetic Instability in Colorectal Cancer Pathogenesis
- (2008) William M. Grady et al. GASTROENTEROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started